HEADER HYDROLASE/INHIBITOR 26-MAY-22 8D0C TITLE HUMAN SARM1 TIR DOMAIN BOUND TO NB-3-ADPR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(+) HYDROLASE SARM1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TIR DOMAIN; COMPND 5 SYNONYM: NADASE SARM1,HSARM1,NADP(+) HYDROLASE SARM1,STERILE ALPHA COMPND 6 AND ARMADILLO REPEAT PROTEIN,STERILE ALPHA AND TIR MOTIF-CONTAINING COMPND 7 PROTEIN 1,STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 2,MYD88-5,SAM COMPND 8 DOMAIN-CONTAINING PROTEIN 2,TIR-1 HOMOLOG,HSTIR; COMPND 9 EC: 3.2.2.6,3.2.2.-; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SARM1, KIAA0524, SAMD2, SARM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NAD, HYDROLASE, AXON DEGENERATION, NEUROSCIENCE, HYDROLASE-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.BRATKOWSKI,P.MATHUR REVDAT 3 25-OCT-23 8D0C 1 REMARK REVDAT 2 30-NOV-22 8D0C 1 JRNL REVDAT 1 21-SEP-22 8D0C 0 JRNL AUTH M.BRATKOWSKI,T.C.BURDETT,J.DANAO,X.WANG,P.MATHUR,W.GU, JRNL AUTH 2 J.A.BECKSTEAD,S.TALREJA,Y.S.YANG,G.DANKO,J.H.PARK,M.WALTON, JRNL AUTH 3 S.P.BROWN,C.M.TEGLEY,P.R.B.JOSEPH,C.H.REYNOLDS,S.SAMBASHIVAN JRNL TITL UNCOMPETITIVE, ADDUCT-FORMING SARM1 INHIBITORS ARE JRNL TITL 2 NEUROPROTECTIVE IN PRECLINICAL MODELS OF NERVE INJURY AND JRNL TITL 3 DISEASE. JRNL REF NEURON V. 110 3711 2022 JRNL REFN ISSN 0896-6273 JRNL PMID 36087583 JRNL DOI 10.1016/J.NEURON.2022.08.017 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 20693 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.670 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 69.9100 - 5.0400 1.00 1470 158 0.1632 0.1773 REMARK 3 2 5.0400 - 4.0000 1.00 1376 146 0.1343 0.1793 REMARK 3 3 4.0000 - 3.4900 1.00 1359 146 0.1564 0.1771 REMARK 3 4 3.4900 - 3.1700 1.00 1349 144 0.1753 0.2149 REMARK 3 5 3.1700 - 2.9500 1.00 1319 142 0.1858 0.2409 REMARK 3 6 2.9500 - 2.7700 1.00 1326 141 0.1975 0.2587 REMARK 3 7 2.7700 - 2.6300 1.00 1334 143 0.1903 0.2617 REMARK 3 8 2.6300 - 2.5200 1.00 1297 139 0.1997 0.2876 REMARK 3 9 2.5200 - 2.4200 1.00 1337 143 0.2027 0.2868 REMARK 3 10 2.4200 - 2.3400 1.00 1290 138 0.1899 0.2526 REMARK 3 11 2.3400 - 2.2700 1.00 1335 142 0.1992 0.2650 REMARK 3 12 2.2600 - 2.2000 1.00 1279 137 0.2246 0.2835 REMARK 3 13 2.2000 - 2.1400 0.99 1330 143 0.2280 0.3211 REMARK 3 14 2.1400 - 2.0900 1.00 1292 138 0.2381 0.2783 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.204 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.614 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2404 REMARK 3 ANGLE : 0.911 3272 REMARK 3 CHIRALITY : 0.055 362 REMARK 3 PLANARITY : 0.007 402 REMARK 3 DIHEDRAL : 19.160 304 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8D0C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265345. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-20 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11584 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20696 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 117.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 11.30 REMARK 200 R MERGE (I) : 0.16500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 10.30 REMARK 200 R MERGE FOR SHELL (I) : 1.05400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 8D0J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PROPANE PH 6.5, 200 MM REMARK 280 POTASSIUM THIOCYANATE, AND 15% POLYETHYLENE GLYCOL 3350, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 43.54300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.61500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.54300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.61500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 983 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 985 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 558 REMARK 465 GLY A 559 REMARK 465 ASP A 560 REMARK 465 SER B 558 REMARK 465 GLY B 559 REMARK 465 ASP B 560 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 561 OG1 CG2 REMARK 470 THR B 561 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 572 -16.28 -141.76 REMARK 500 GLU A 599 -146.22 -113.12 REMARK 500 GLU B 599 -149.25 -117.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8D0H RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0J RELATED DB: PDB REMARK 900 SAME PROTEIN, APO REMARK 900 RELATED ID: 8D0E RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0D RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0F RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0G RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0I RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND REMARK 900 RELATED ID: 8D0M RELATED DB: PDB REMARK 900 DIFFERENT PROTEIN, SAME CITATION DBREF 8D0C A 558 700 UNP Q6SZW1 SARM1_HUMAN 558 700 DBREF 8D0C B 558 700 UNP Q6SZW1 SARM1_HUMAN 558 700 SEQRES 1 A 143 SER GLY ASP THR PRO ASP VAL PHE ILE SER TYR ARG ARG SEQRES 2 A 143 ASN SER GLY SER GLN LEU ALA SER LEU LEU LYS VAL HIS SEQRES 3 A 143 LEU GLN LEU HIS GLY PHE SER VAL PHE ILE ASP VAL GLU SEQRES 4 A 143 LYS LEU GLU ALA GLY LYS PHE GLU ASP LYS LEU ILE GLN SEQRES 5 A 143 SER VAL MET GLY ALA ARG ASN PHE VAL LEU VAL LEU SER SEQRES 6 A 143 PRO GLY ALA LEU ASP LYS CYS MET GLN ASP HIS ASP CYS SEQRES 7 A 143 LYS ASP TRP VAL HIS LYS GLU ILE VAL THR ALA LEU SER SEQRES 8 A 143 CYS GLY LYS ASN ILE VAL PRO ILE ILE ASP GLY PHE GLU SEQRES 9 A 143 TRP PRO GLU PRO GLN VAL LEU PRO GLU ASP MET GLN ALA SEQRES 10 A 143 VAL LEU THR PHE ASN GLY ILE LYS TRP SER HIS GLU TYR SEQRES 11 A 143 GLN GLU ALA THR ILE GLU LYS ILE ILE ARG PHE LEU GLN SEQRES 1 B 143 SER GLY ASP THR PRO ASP VAL PHE ILE SER TYR ARG ARG SEQRES 2 B 143 ASN SER GLY SER GLN LEU ALA SER LEU LEU LYS VAL HIS SEQRES 3 B 143 LEU GLN LEU HIS GLY PHE SER VAL PHE ILE ASP VAL GLU SEQRES 4 B 143 LYS LEU GLU ALA GLY LYS PHE GLU ASP LYS LEU ILE GLN SEQRES 5 B 143 SER VAL MET GLY ALA ARG ASN PHE VAL LEU VAL LEU SER SEQRES 6 B 143 PRO GLY ALA LEU ASP LYS CYS MET GLN ASP HIS ASP CYS SEQRES 7 B 143 LYS ASP TRP VAL HIS LYS GLU ILE VAL THR ALA LEU SER SEQRES 8 B 143 CYS GLY LYS ASN ILE VAL PRO ILE ILE ASP GLY PHE GLU SEQRES 9 B 143 TRP PRO GLU PRO GLN VAL LEU PRO GLU ASP MET GLN ALA SEQRES 10 B 143 VAL LEU THR PHE ASN GLY ILE LYS TRP SER HIS GLU TYR SEQRES 11 B 143 GLN GLU ALA THR ILE GLU LYS ILE ILE ARG PHE LEU GLN HET Q1F A 801 53 HET Q1F B 801 53 HETNAM Q1F [[(2~{R},3~{S},4~{R},5~{R})-5-(6-AMINOPURIN-9-YL)-3,4- HETNAM 2 Q1F BIS(OXIDANYL)OXOLAN-2-YL]METHOXY-OXIDANYL-PHOSPHORYL] HETNAM 3 Q1F [(2~{R},3~{S},4~{R},5~{R})-5-[4-[(1~{S})-1-[METHYL-[2, HETNAM 4 Q1F 2,2-TRIS(FLUORANYL)ETHYLCARBAMOYL]AMINO]ETHYL]PYRIDIN- HETNAM 5 Q1F 1-YL]-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHYL HYDROGEN HETNAM 6 Q1F PHOSPHATE FORMUL 3 Q1F 2(C26 H36 F3 N8 O14 P2 1+) FORMUL 5 HOH *200(H2 O) HELIX 1 AA1 ARG A 569 HIS A 587 1 19 HELIX 2 AA2 ILE A 593 LEU A 598 1 6 HELIX 3 AA3 LYS A 602 ALA A 614 1 13 HELIX 4 AA4 LEU A 626 MET A 630 5 5 HELIX 5 AA5 ASP A 637 CYS A 649 1 13 HELIX 6 AA6 GLU A 664 LEU A 668 5 5 HELIX 7 AA7 PRO A 669 PHE A 678 5 10 HELIX 8 AA8 TYR A 687 LEU A 699 1 13 HELIX 9 AA9 ARG B 569 HIS B 587 1 19 HELIX 10 AB1 ILE B 593 LEU B 598 1 6 HELIX 11 AB2 LYS B 602 ALA B 614 1 13 HELIX 12 AB3 LEU B 626 MET B 630 5 5 HELIX 13 AB4 ASP B 637 CYS B 649 1 13 HELIX 14 AB5 GLU B 664 LEU B 668 5 5 HELIX 15 AB6 MET B 672 PHE B 678 5 7 HELIX 16 AB7 TYR B 687 LEU B 699 1 13 SHEET 1 AA1 5 VAL A 591 PHE A 592 0 SHEET 2 AA1 5 VAL A 564 SER A 567 1 N VAL A 564 O PHE A 592 SHEET 3 AA1 5 ASN A 616 LEU A 621 1 O VAL A 620 N SER A 567 SHEET 4 AA1 5 ASN A 652 ILE A 657 1 O VAL A 654 N PHE A 617 SHEET 5 AA1 5 ILE A 681 LYS A 682 1 O ILE A 681 N ILE A 657 SHEET 1 AA2 5 VAL B 591 PHE B 592 0 SHEET 2 AA2 5 VAL B 564 SER B 567 1 N VAL B 564 O PHE B 592 SHEET 3 AA2 5 ASN B 616 LEU B 621 1 O VAL B 618 N PHE B 565 SHEET 4 AA2 5 ASN B 652 ILE B 657 1 O ILE B 656 N LEU B 619 SHEET 5 AA2 5 ILE B 681 LYS B 682 1 O ILE B 681 N ILE B 657 CRYST1 87.086 117.230 32.865 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011483 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008530 0.000000 0.00000 SCALE3 0.000000 0.000000 0.030428 0.00000